<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81032</article-id><article-id pub-id-type="doi">10.7554/eLife.81032</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Gain-of-function variants in the ion channel gene <italic>TRPM3</italic> underlie a spectrum of neurodevelopmental disorders</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-283363"><name><surname>Burglen</surname><given-names>Lydie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-181307"><name><surname>Van Hoeymissen</surname><given-names>Evelien</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3897-8998</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283381"><name><surname>Qebibo</surname><given-names>Leila</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283366"><name><surname>Barth</surname><given-names>Magalie</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283367"><name><surname>Belnap</surname><given-names>Newell</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283368"><name><surname>Boschann</surname><given-names>Felix</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283369"><name><surname>Depienne</surname><given-names>Christel</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298807"><name><surname>De Clercq</surname><given-names>Katrien</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283370"><name><surname>Douglas</surname><given-names>Andrew GL</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283371"><name><surname>Fitzgerald</surname><given-names>Mark P</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283372"><name><surname>Foulds</surname><given-names>Nicola</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283373"><name><surname>Garel</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283374"><name><surname>Helbig</surname><given-names>Ingo</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283375"><name><surname>Held</surname><given-names>Katharina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283376"><name><surname>Horn</surname><given-names>Denise</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0870-8911</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283377"><name><surname>Janssen</surname><given-names>Annelies</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6735-8248</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53521"><name><surname>Kaindl</surname><given-names>Angela M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9454-206X</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283378"><name><surname>Narayanan</surname><given-names>Vinodh</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0658-3847</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283379"><name><surname>Pragner</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283380"><name><surname>Rupin</surname><given-names>Mailys</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283365"><name><surname>Afenjar</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143698"><name><surname>Zhao</surname><given-names>Siyuan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2005-9440</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298808"><name><surname>Ramaekers</surname><given-names>Vincent Th</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283382"><name><surname>Ruggiero</surname><given-names>Sarah M</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283383"><name><surname>Thomas</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283384"><name><surname>Valence</surname><given-names>Stéphanie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283385"><name><surname>Van Maldergem</surname><given-names>Lionel</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178738"><name><surname>Rohacs</surname><given-names>Tibor</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3580-2575</contrib-id><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283386"><name><surname>Rodriguez</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283387"><name><surname>Dyment</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283388"><name><surname>Voets</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-180349"><name><surname>Vriens</surname><given-names>Joris</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2502-0409</contrib-id><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Developmental Brain Disorders Laboratory</institution>, <institution>INSERM UMR 1163</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff><aff id="aff3"><institution content-type="dept">Département de Génétique</institution>, <institution>Hôpitaux Universitaires Paris-Ouest</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">Department of Genetics</institution>, <institution>Centre Hospitalier Universitaire d'Angers</institution>, <addr-line><named-content content-type="city">Angers</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">Neurogenomics Division</institution>, <institution>Translational Genomics Research Institute</institution>, <addr-line><named-content content-type="city">Phoenix</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Institute of Medical Genetics and Human Genetics</institution>, <institution>Charité - Universitäts medizin Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff7"><institution content-type="dept">Institute of Human Genetics</institution>, <institution>Essen University Hospital</institution>, <addr-line><named-content content-type="city">Essen</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution>University Hospital Southampton NHS Foundation Trust</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff9"><institution>Children's Hospital of Philadelphia</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Wessex Clinical Genetics Service</institution>, <institution>University Hospital Southampton NHS Foundation Trust</institution>, <addr-line><named-content content-type="city">Wessex</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff11"><institution content-type="dept">Institute of Cell Biology and Neurobiology</institution>, <institution>Charité - Universitätsmedizin Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff12"><institution content-type="dept">Department of Pediatric Neurology</institution>, <institution>Charité - Universitäts medizin Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff13"><institution content-type="dept">Department of Neuropediatrics</institution>, <institution>Centre Hospitalier Universitaire d'Angers</institution>, <addr-line><named-content content-type="city">Angers</named-content></addr-line>, <country>France</country></aff><aff id="aff14"><institution content-type="dept">Department of Pharmacology, Physiology and Neuroscience</institution>, <institution>Rutgers, The State University of New Jersey</institution>, <addr-line><named-content content-type="city">Newark</named-content></addr-line>, <country>United States</country></aff><aff id="aff15"><institution content-type="dept">Division Neuropediatrics</institution>, <institution>University of Liège</institution>, <addr-line><named-content content-type="city">Liège</named-content></addr-line>, <country>Belgium</country></aff><aff id="aff16"><institution content-type="dept">Wessex Regional Genetics Laboratory</institution>, <institution>Salisbury District Hospital</institution>, <addr-line><named-content content-type="city">Wessex</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff17"><institution content-type="dept">Centre de Génétique Humaine</institution>, <institution>Centre Hospitalier Universitaire de Besançon</institution>, <addr-line><named-content content-type="city">Besancon</named-content></addr-line>, <country>France</country></aff><aff id="aff18"><institution content-type="dept">Children's Hospital of Eastern Ontario Research Institute</institution>, <institution>University of Ottawa</institution>, <addr-line><named-content content-type="city">Ottawa</named-content></addr-line>, <country>Canada</country></aff><aff id="aff19"><institution content-type="dept">Department of Development and Regeneration</institution>, <institution>KU Leuven</institution>, <addr-line><named-content content-type="city">Leuven</named-content></addr-line>, <country>Belgium</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-41815"><name><surname>Jara-Oseguera</surname><given-names>Andrés</given-names></name><role>Reviewing editor</role><aff><institution>The University of Texas at Austin</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Thomas.Voets@vib.kuleuven.be</email> (TV);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Joris.Vriens@kuleuven.be</email> (JV);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e81032</elocation-id><history><date date-type="received"><day>13</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>07</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Burglen et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Burglen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81032-v1.pdf"/><abstract><p>TRPM3 is a temperature- and neurosteroid-sensitive plasma membrane cation channel expressed in a variety of neuronal and non-neuronal cells. Recently, rare <italic>de novo</italic> variants in <italic>TRPM3</italic> were identified in individuals with developmental and epileptic encephalopathy (DEE), but the link between TRPM3 activity and neuronal disease remains poorly understood. We previously reported that two disease-associated variants in TRPM3 lead to a gain of channel function (Van Hoeymissen et al., 2020; Zhao et al., 2020). Here, we report a further ten patients carrying one of seven additional heterozygous <italic>TRPM3</italic> missense variants. These patients present with a broad spectrum of neurodevelopmental symptoms, including global developmental delay, intellectual disability, epilepsy, musculo-skeletal anomalies, and altered pain perception. We describe a cerebellar phenotype with ataxia or severe hypotonia, nystagmus, and cerebellar atrophy in more than half of the patients. All disease-associated variants exhibited a robust gain-of-function phenotype, characterized by increased basal activity leading to cellular calcium overload and by enhanced responses to the neurosteroid ligand pregnenolone sulphate, when co-expressed with wild-type TRPM3 in mammalian cells. The antiseizure medication primidone, a known TRPM3 antagonist, reduced the increased basal activity of all mutant channels. These findings establish gain-of-function of TRPM3 as the cause of a spectrum of autosomal dominant neurodevelopmental disorders with frequent cerebellar involvement in humans, and provide support for the evaluation of TRPM3 antagonists as a potential therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010460</institution-id><institution>Flanders' FOOD</institution></institution-wrap></funding-source><award-id>G.0D1417N</award-id><principal-award-recipient><name><surname>Vriens</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010460</institution-id><institution>Flanders' FOOD</institution></institution-wrap></funding-source><award-id>G.084515N</award-id><principal-award-recipient><name><surname>Vriens</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010460</institution-id><institution>Flanders' FOOD</institution></institution-wrap></funding-source><award-id>G.0A6719N</award-id><principal-award-recipient><name><surname>Vriens</surname><given-names>Joris</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010460</institution-id><institution>Flanders' FOOD</institution></institution-wrap></funding-source><award-id>11E782</award-id><principal-award-recipient><name><surname>Van Hoeymissen</surname><given-names>Evelien</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was performed in accordance with the guidelines specified by the institutional review boards and ethics committees at each institution. Information of institutional protocols are provided in the section of Material &amp; Methods. All parents agreed on sharing and publicing the patients' information.Patients information:patient 1, 3, 4, 7: Written informed consent was obtained from the parents of the probands for molecular genetic analysis and possible publication of the anonymized clinical data. The study was done in accordance with local research and ethics requirements.patient 2: Parents signed an informed consent, received a genetic counselling before and after the analysis, and the genetic study was performed in accordance with German and French ethical requirements and laws.patient 5: UK ethical approval by the Cambridge South Research Ethics Committee (10/H0305/83)patient 6: outine clinical care within the UK National Health Service, and so no specific institutional ethical approval was requiredpatient 8:  Declaration of Helsinki with local approval by the Children's Hospital of Philadelphia (CHOP) Institutional Review Board (IRB 15-12226).patient 9: The participating family signed the IRB research protocol of the University of Pennsylvania division of Neurologypatient 10: The study protocol and consent documents were approved by the Western Institutional Review Board (WIRB # 20120789). The retrospective analysis of epilepsy patient data was approved by the local ethics committees of the Charité (approval no. EA2/084/18)</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Raw data for the following figures are made available via figshare (https://doi.org/10.6084/m9.figshare.21799604): Figure 1 - Figure Supplement 1; Figure 3; Figure 3 - Figure Supplement 1, 2, 3 and 4; Figure 4; Figure 4 - Figure Supplement 1, 2 and 3.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Evelien Van Hoeymissen and Tibor Rohacs</collab></person-group><year iso-8601-date="2022">2022</year><source>Data of Evelien Van Hoeymissen for manuscript &quot;Gain-of-function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders&quot;</source><ext-link ext-link-type="uri" xlink:href="https://figshare.com/articles/dataset/Data_of_Evelien_Va_Hoeymissen_for_manuscript_Gain-of-function_variants_in_the_ion_channel_gene_TRPM3_underlie_a_spectrum_of_neurodevelopmental_disorders_/21799604">https://figshare.com/articles/dataset/Data_of_Evelien_Va_Hoeymissen_for_manuscript_Gain-of-function_variants_in_the_ion_channel_gene_TRPM3_underlie_a_spectrum_of_neurodevelopmental_disorders_/21799604</ext-link><comment>https://doi.org/10.6084/m9.figshare.21799604</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-81032-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>